Key Events This Week
30 Mar: Stock hits 52-week low of Rs.128
01 Apr: Intraday high surge of 7.02% to Rs.135
02 Apr: Mild correction to Rs.138.60 (-1.46%)
03 Apr: No trading data available
May 06
BSE+NSE Vol: 60.68 k

Shalby Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
The Sensex rose 0.59% on 27 Apr 2026, yet Shalby Ltd. outpaced the broader market with a robust 9.51% gain, reaching an intraday high of Rs 167.4. This 5.31 percentage-point outperformance over its Hospital sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Shalby Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Shalby Ltd., a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 1.69%, the stock faces mixed technical signals that warrant close attention from investors navigating a challenging market environment.
Read full news article
Shalby Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
The Sensex advanced 3.72% on 8 Apr 2026, yet Shalby Ltd. outpaced the broader market with a 7.33% gain, marking a 5.86-percentage-point outperformance over its Hospital sector peers. This sharp intraday surge, culminating in a high of Rs 154.2, rewrites the short-term narrative for the stock amid a backdrop of recent weakness.
Read full news article
30 Mar: Stock hits 52-week low of Rs.128
01 Apr: Intraday high surge of 7.02% to Rs.135
02 Apr: Mild correction to Rs.138.60 (-1.46%)
03 Apr: No trading data available

The Sensex declined by 2.16% on 1 Apr 2026, while Shalby Ltd. surged 7.02%, outperforming its hospital sector peers by 5.5 percentage points. This sharp single-session gain stands out amid a broadly weak market environment, signalling a stock-specific event rather than a market-wide rally.
Read full news article
Shalby Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Read full news articleResignation of Mr. Vijay Kishanlal Kedia as an Independent Director w.e.f. April 30 2026
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Shalby Ltd |
| 2 | CIN NO. | L85110GJ2004PLC044667 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 120.32 |
| 4 | Highest Credit Rating during the previous FY | A+ |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | ICRA LIMITED |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | NSE |
Intimation of receipt pf approval for kidney transplant of Shalby Hospitals Krishna unit-Regulation 30 SEBI LODR
No Upcoming Board Meetings
Shalby Ltd. has declared 12% dividend, ex-date: 19 Sep 24
No Splits history available
No Bonus history available
No Rights history available